Skip to content

IQVIA MedTech NV

Active
Public limited companyfounded 2005active for 21 yearsBerchemstadionstraat 78, 2600 Antwerpen, Belgium25 active companies are registered at this addressKBO/BCE: BE 0873.863.003

From the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of IQVIA MedTech NV is 2.1% (moderate). For IQVIA MedTech NV, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €34.2m and a net result of -€3.5m. Equity is growing by about 49% per year across the filed financial years. Its solvency ranks better than 74% of 1,096 sector peers (NACE 71, financial year 2023). The company has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
IQVIA MedTech NVActive
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 18-05-2005 Normal situation
Legal form
Public limited company
Registered office
Berchemstadionstraat 78, 2600 Antwerpen
Activity
Other technical testing and analysis NACE 71209and 3 others
Establishment unit
2.147.958.892 2600 Antwerpen, since 12-07-2005
Financial year end
31 December
Peppol
Reachable
Company details

Who decides

Board
Auditor
Mazars Bedrijfsrevisoren CV
Shareholders
Board & ownership

How it is doing

Bankruptcy probabilitywithin 12 months
2.1%
2023 figures too old to score
Annual accounts 2023
Turnover
€5.6m
▼ 64.0%
Loss
€3.5m
Equity
€34.2m
▲ 205%
Total assets
€52.2m
▲ 118%
Staff
31.6 FTE
=
2024 accounts not filed, 458 days past the deadline
Filed on 23-12-2024PDF
Financials
Signalsraises riskFigures for financial year 2023 (filed 24-12-2024)2 financial years not filed after the legal deadline; last filed accounts filed 145 days late; 2 of the last 3 lateLoss of €3.5m (financial year 2023)Two or more financial years not filed2023 accounts filed 145 days latelowers riskSector: Architectural and engineering activities; technical testing and analysis (NACE 71)Show the evidence

Bankruptcy probability

No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Filing: At least two filing cycles are missing
Financial strength, FY 2023 · tick = 2022
Average
Solvency 90+18
equity 65.5% of total assets
Liquidity 47=
short-term debt 33.7% · cash 9.6%
Profitability 10-51
return on assets -6.8%
Bankruptcy probability, 12 months
2.1% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (690 companies, NACE 71, small)
Last 24 months 11-2024: 1.7% 12-2024: 1.7%● unchanged vs 11-2024 01-2025: 0.6%▼ -1.1 percentage points vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.6%● unchanged vs 03-2025 05-2025: 0.5%▼ -0.1 percentage points vs 04-2025 06-2025: 0.5%● unchanged vs 05-2025 07-2025: 0.5%● unchanged vs 06-2025 08-2025: 0.7%▲ +0.2 percentage points vs 07-2025 09-2025: 0.4%▼ -0.3 percentage points vs 08-2025lowest value 10-2025: 0.5%▲ +0.1 percentage points vs 09-2025 11-2025: 0.6%▲ +0.1 percentage points vs 10-2025 12-2025: 0.7%▲ +0.1 percentage points vs 11-2025 01-2026: 1.5%▲ +0.8 percentage points vs 12-2025 02-2026: 1.5%● unchanged vs 01-2026 03-2026: 1.5%● unchanged vs 02-2026 04-2026: 1.3%▼ -0.2 percentage points vs 03-2026 05-2026: 1.3%● unchanged vs 04-2026 06-2026: 1.3%● unchanged vs 05-2026 07-2026: 1.3%● unchanged vs 06-2026 08-2026: 2.1%▲ +0.8 percentage points vs 07-2026highest value 09-2026: 2.1%● unchanged vs 08-2026highest value 10-2026: 2.1%● unchanged vs 09-2026
Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2023 (filed 24-12-2024)
NBB · annual accounts
raises risk · 2 financial years not filed after the legal deadline; last filed accounts filed 145 days late; 2 of the last 3 late
NBB · filings
lowers risk · Sector: Architectural and engineering activities; technical testing and analysis (NACE 71)
KBO
raises risk · Loss of €3.5m (financial year 2023)
NBB · annual accounts
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 8 filings
Position against the passed deadline
31-12-2024 year end31-07-2025 deadline01-11-2026 today
raises risk · 2023 accounts filed 145 days late
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 23-12-2024, 145 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 8 filings
Deviation from the deadline
2025
not filed
2024
not filed
2023
145 days late
2022
592 days late
2021
3 days early
2020
26 days early
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 141 days after the deadline; the sector median (NACE 71) for financial year 2024 is 8 days before the deadline, and 34% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Caution: From profit to loss in 2023after €575,833 in 2022 -€3.5m View
  • Caution: Among the weakest 5% on net resultsector median €36,230 · 1,098 companies -€3.5m View

Documents

Annual accounts at the NBB

All 20 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about IQVIA MedTech NV

What is the company number of IQVIA MedTech NV?
0873.863.003. In Belgium the VAT number is the company number with BE in front: BE 0873.863.003.
Where is IQVIA MedTech NV based?
The registered office is at Berchemstadionstraat 78, 2600 Antwerpen.Company details
What does IQVIA MedTech NV do?
According to the KBO register, the main activity is other technical testing and analysis (NACE 71209).
What is the legal form of IQVIA MedTech NV?
Public limited company (NV).
When was IQVIA MedTech NV founded?
On 18-05-2005.
Is IQVIA MedTech NV still active?
Yes, IQVIA MedTech NV is an active enterprise in the KBO register.
How many employees does IQVIA MedTech NV have?
On average 31.6 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of IQVIA MedTech NV?
€5.6m in financial year 2023, according to the filed annual accounts.
Is IQVIA MedTech NV profitable?
In financial year 2023, IQVIA MedTech NV made a loss of €3.5m.
Where can I find the annual accounts of IQVIA MedTech NV?
IQVIA MedTech NV filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.Annual accounts 2023 (PDF)

Companies related to IQVIA MedTech NV

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure